KREMI reports 52% decline in year-end net profit

July 16, 2025

Caribbean Cream Limited (KREMI)

Audited financials for the year end ended February 28, 2025:

Caribbean Cream Limited (Kremi) reported a 13% increase in Revenue, totaling $2.99 billion, for the year ended February 28, 2025, compared to $2.64 billion in the corresponding period last year. Revenue for the fourth quarter increased by 7% to $818.21 million, compared to $762.68 million for the comparable quarter in 2024.

Cost of Sales amounted to $1.94 billion (2023: $1.72 billion), representing an increase of 13% year over year. Consequently, gross profit increased by 15% to $1.06 billion compared to $923.61 million for the year end ended February 28, 2024. The company booked a gross profit of $330.86 million for the fourth quarter, versus $296.76 million reported for the same quarter in 2024.

Administrative expenses increased by 21% to close at $867.98 million (2024: $716.46 million), while Selling and distribution costs increased by 8% from $74.59 million in 2024 to $80.34 million in the period under review. As a result, total expenses for the year ended February 28, 2025, amounted to $948.32 million, representing a 20% increase from the $791.05 million reported in 2024.

Operating Profit for the year end ended February 28, 2025, amounted to $118.78 million, an 11% decrease relative to $133.22 million reported in 2024. Operating Profit for the fourth quarter amounted to $46.62 million (2024: $19.53 million). Finance costs totaled $99.80 million, representing a 20% increase from the corresponding period in the previous year. (2024: $83.15 million).

Profits before taxation for the year-end ended February 28, 2025, amounted to $18.58 million, a 61% decrease relative to the $48.21 million reported in 2024. Profits before taxation for the fourth quarter amounted to $15.70 million (2024: $1.58 million).

The tax charge for the year ended February 28, 2025, decreased by 93% to $792,967 (2024: $11.47 million). Net Profit for the year end amounted to $17.79 million, a 52% decrease from the $36.74 million reported in 2024. For the fourth quarter, Net Profit was $15.63 million (2024: $812,791).

Consequently, Earnings Per Share for the year end amounted to $0.05 (2024: EPS: $0.10), while Earnings Per Share for the quarter totaled $0.04 (2024: EPS: $0.002). The number of shares used in these calculations was 378,568,115.

Notably, Kremi’s stock price closed the trading period on July 15, 2025, at $3.45, with a corresponding P/E ratio of 73.41x.

 

Balance Sheet Highlights

The company’s assets totaled $2.70 billion (as of 2024: $2.52 billion). The total increase in the company’s asset base is driven by a 68% YoY increase in Inventories ending the year at $368 million (2024: $219.03 million), and a 218% YoY increase in Right-of-use assets ending the year at $254.10 million (2024: $79.83 million).

 

Shareholders’ equity was $880.15 million (2024: $862.36 million), representing a book value per share of $2.32 (2024: $2.28).

 

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_537598660
March12, 2026 Blue Power Group Limited (BPOW) Unaudited financials for the nine months ended January 31, 2026: Blue Power Group Limited (BPOW) for …
shutterstock_148562033
March 12, 2026   Wisynco Group Limited (WISYNCO) has advised that on March 9, 2026, Executives sold a total of 2,594,821 WISYNCO shares. …
shutterstock_453968572
March 12, 2026 United States: US Trade Gap Narrowed in January by More Than Projected   The US trade deficit narrowed in January as export…
shutterstock_342262439
March 11, 2025   Indies Pharma Jamaica Limited (INDIES) has advised that at a meeting of its Board of Directors to be held on March 23, 202…
shutterstock_453968572
March 11, 2025   Kintyre Holdings (JA) Limited (KNTYR) has advised that the Company has been notified that a group of principal shareholder…
shutterstock_148562033
March 11, 2026   A.S. Bryden & Sons Holdings Limited (ASBH) has advised that on February 16, 2026, a connected party purchased 282,704 …
shutterstock_148562033
March 11, 2025   Seprod Limited (SEP) has advised that on February 20, 2026, a Director sold 5,787,413 SEP shares and a connected party pur…
shutterstock_537598660
March 11, 2026 Weekly Pick 11.03.2026 JMMBGL Disclaimer: Analyst Certification -The views expressed in this research report accurately refl…